NP / PA
Kaczmarek, Alana
Kaczmarek, Alana was paid $110K by Medicaid between Jul 2020 and Mar 2023, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoKACZMAREK, ALANA
HOLYOKE, MA 01040
HOLYOKE, MA 01040
33aNPI1396860599assigned 03/20/2007
33bProvider typePediatric Nurse Practitioner
28Total paid$110K
24GClaims2,133
24DCodes billed12
24AFirst – last monthJul 2020 – Mar 2023
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Massachusetts
Rank by total paid#12 of 125
Median peer was paid$6K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 222 | $7K | |
| 2021 | 773 | $49K | |
| 2022 | 983 | $46K | |
| 2023 | 155 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 640 | 636 | $36K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 341 | 339 | $36K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 26% | 563 | 560 | $28K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.5% | 90 | 90 | $4K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 1.8% | 217 | 217 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 45 | 45 | $1K |
| 99051 | <1% | 60 | 60 | $993.60 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 98 | 79 | $930.55 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 13 | 13 | $158.73 |
| 96127 | <1% | 14 | 14 | $143.78 | |
| 99177 | <1% | 24 | 24 | $89.28 | |
| 99072 | 0% | 28 | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.